FDA Approved: CITALOPRAM — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)

View source ↗

Summary

The FDA approved a supplemental application for the generic antidepressant citalopram submitted by Chartwell Governmental & Specialty RX, LLC (ANDA077629).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Citalopram (Citalopram hydrobromide)

Snippet

SUPPL AP for CITALOPRAM (CITALOPRAM)